These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8502705)

  • 21. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 22. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon.
    Farci P; Karayiannis P; Brook MG; Smedile A; Lai ME; Balestrieri A; Saldanha JA; Monjardino J; Gerin J; Thomas HC
    Q J Med; 1989 Nov; 73(271):1045-54. PubMed ID: 2623137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.
    Mederacke I; Filmann N; Yurdaydin C; Bremer B; Puls F; Zacher BJ; Heidrich B; Tillmann HL; Rosenau J; Bock CT; Savas B; Helfritz F; Lehner F; Strassburg CP; Klempnauer J; Wursthorn K; Lehmann U; Manns MP; Herrmann E; Wedemeyer H
    J Hepatol; 2012 Jan; 56(1):115-22. PubMed ID: 21762665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Prog Clin Biol Res; 1991; 364():385-91. PubMed ID: 2020713
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic significance of IgM anti-HD during interferon therapy.
    Marinucci G; Hassan G; Di Giacomo C; Dato A; Barlattani A; Costa F
    Prog Clin Biol Res; 1993; 382():311-8. PubMed ID: 8502696
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence that hepatitis D virus needs hepatitis B virus to cause hepatocellular damage.
    Davies SE; Lau JY; O'Grady JG; Portmann BC; Alexander GJ; Williams R
    Am J Clin Pathol; 1992 Dec; 98(6):554-8. PubMed ID: 1462952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection.
    Lau JY; King R; Tibbs CJ; Catterall AP; Smith HM; Portmann BC; Alexander GJ; Williams R
    J Med Virol; 1993 Apr; 39(4):292-6. PubMed ID: 8492101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the presence of two forms of delta antigen in liver tissues of acute versus chronic delta hepatitis.
    Govindarajan S; Hwang S; Lai MM
    Prog Clin Biol Res; 1993; 382():139-43. PubMed ID: 8502671
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of reactivation of chronic hepatitis delta infection.
    Govindarajan S; Smedile A; De Cock KM; Valinluck B; Redeker AG; Gerin JL
    J Hepatol; 1989 Sep; 9(2):204-8. PubMed ID: 2809161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic hepatitis D with interferon alfa-2a.
    Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
    N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis delta virus superinfection in Guangzhou area.
    Chen GH; Zhang MD; Huang W
    Chin Med J (Engl); 1990 Jun; 103(6):451-4. PubMed ID: 2119957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential roles for HDAg-p24 and -p27 in HDV pathogenesis.
    Cole SM; Macnaughton TB; Gowans EJ
    Prog Clin Biol Res; 1993; 382():131-8. PubMed ID: 8502670
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection.
    Gowans EJ; Baroudy BM; Negro F; Ponzetto A; Purcell RH; Gerin JL
    Virology; 1988 Nov; 167(1):274-8. PubMed ID: 3188398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta viral replication markers in acute and chronic D infection.
    Buti M
    Prog Clin Biol Res; 1991; 364():201-5. PubMed ID: 2020696
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
    Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
    Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
    Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in hepatitis D virus biology and disease.
    Smedile A; Rizzetto M; Gerin JL
    Prog Liver Dis; 1994; 12():157-75. PubMed ID: 7746872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.